WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark HAEMATOKINE was filed as Word mark on 02/05/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1596176 |
| Register number | 018286902 |
| Countries | 
|
| Base trademark |
No. 018286902,
December 11, 2020
|
| Application date | February 5, 2021 |
| Expiration date | February 5, 2031 |
Trademark owner
Joukahaisenkatu 6
20520 Turku
FI
20520 Turku
FI
Trademark representatives
Eteläinen Rautatiekatu 10 A
00100 Helsinki
FI
goods and services
01
Chemicals for use in industry, science and photography, as
well as in agriculture, horticulture and forestry;
biological preparations for use in industry and science;
media for cell culture for use in the biotechnological
industry; media for cell culture for use in non-medical
research laboratories; biological preparation for use in
cell cultures other than for medical or veterinary use;
culture media for microbiology; cell growth media for
growing cells for scientific use; cultures, other than for
medical or veterinary use; cultures of cell media [other
than for medical or veterinary use]; cultures of
microorganisms, other than for medical and veterinary use;
blood culture media for scientific use; biological
preparations, other than for medical or veterinary purposes;
stem cells, other than for medical or veterinary purposes;
stem cells for scientific purposes; stem cells for research
purposes
05
Pharmaceuticals, medical and veterinary preparations;
sanitary preparations for medical purposes; stem cells; stem
cells for medical purposes; tumor suppressing agents;
antineoplastics; anti-neoplastic preparations of chemical
origin; anti-neoplastic preparations of microbial origin;
anti-cancer preparations; compounds for treating cancer;
antibodies; antibodies for medical use to treat inflammation
and cancer growth and spread; adjuvants for medical
purposes; vaccine adjuvants; biological adjuvants for
medical purposes; anti-inflammatories; antigens; antitumor
drugs; biological preparations for the treatment of cancer;
biopharmaceuticals for the treatment of cancer;
biotechnological preparations for medical use; culture media
for medical use; media for bacteriological cultures; cell
growth media for growing cells for medical use; biological
preparations for medical purposes; mixed biological
preparations for medical purposes; biological preparations
for veterinary purposes; immunomodulators; immunostimulants;
injectable pharmaceuticals; pharmaceutical preparations for
the treatment of viral diseases; pharmaceutical preparations
for the treatment of bone diseases; pharmaceutical
preparations for use in chemotherapy; pharmaceutical
preparations for the treatment of infectious diseases;
pharmaceutical preparations for the treatment of immune
system related diseases and disorders; pharmaceutical
preparations for use in oncology; pharmaceutical
preparations for activating cellular function;
pharmaceutical preparations for immunity adjustment;
pharmaceutical preparations for regulating the immune
system; pharmaceutical preparations for treating malignant
tumors; pharmaceutical preparations for suppressing tumors;
pharmaceutical preparations for the treatment of autoimmune
diseases; pharmaceutical preparations for the prevention of
tumours; pharmaceutical preparations and substances for use
in oncology; pharmaceutical preparations and substances with
anti-inflammatory properties; pharmaceutical preparations
and substances for the treatment of cancer; pharmaceutical
preparations for the treatment of autoimmune disorders;
pharmaceutical preparations for use in hematology;
pharmaceutical preparations for the prevention of diseases
of the immune system; pharmaceutical preparations for the
prevention of disorders of the immune system; pharmaceutical
preparations for the prevention of autoimmune diseases;
pharmaceutical preparations for the treatment of disorders
caused by bacteria; pharmaceutical preparations for the
treatment of diseases caused by bacteria; pharmaceutical
preparations for the prevention of disorders of the
respiratory system; pharmaceutical preparations for the
prevention of inflammatory disorders; pharmaceutical
preparations for the prevention of autoimmune disorders;
pharmaceutical preparations for the prevention of
inflammatory diseases; pharmaceutical preparations for the
treatment of inflammatory diseases; pharmaceutical
preparations for the treatment of cancer; pharmaceutical
preparations for use in tissue transplantation;
pharmaceutical products for the treatment of bone diseases;
regulatory proteins for medical use; serotherapeutic
medicines; synthetic peptides for pharmaceutical purposes;
pharmaceutical products for treating respiratory diseases;
compounds for treating respiratory diseases; pharmaceutical
preparations for treating respiratory diseases; compounds
for treating correlated pulmonary syndromes; pharmaceutical
preparations for treatment and prevention of ischemic
conditions, inflammation and organ damages resulting from
tissue traumas, reperfusion injuries, cancer, cancer
metastasis, inflammatory conditions and allergic conditions;
pharmaceutical preparations for treatment and prevention of
multi-organ failure, acute lung injury and acute respiratory
distress syndrome in adults, adolescents, children, infants
and neonates
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 2, 2023 | 2023/31 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| December 1, 2022 | 2022/49 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 15, 2022 | 2022/38 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 9, 2022 | 2022/37 Gaz | CA | Rejection |
| August 23, 2022 | 2022/34 Gaz | KR | Rejection |
| May 5, 2022 | 2022/18 Gaz | CH | Rejection |
| April 7, 2022 | 2022/14 Gaz | JP | Rejection |
| November 30, 2021 | 2021/49 Gaz | NZ | Rejection |
| November 29, 2021 | 2021/50 Gaz | RAW: Limitation | |
| October 22, 2021 | 2021/45 Gaz | CN | Rejection |
| September 27, 2021 | 2021/39 Gaz | US | Rejection |
| August 26, 2021 | 2021/34 Gaz | AU | Rejection |
| June 28, 2021 | 2021/27 Gaz | IN | Rejection |
| February 5, 2021 | 2021/21 Gaz | EM | Registration |
ID: 141596176